Biofil Chemicals & Pharmaceuticals Limited
NSE: BIOFILCHEM | Information Technology
Market Fundamentals
Stock Intelligence & News
Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure as required under sub-clause 7 of Para A of Part A of Schedule III regarding 1. Continuation of directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-Executive Independent Director of the Company, upon attaining the age of 75 (seventy-five) years. |SUBJECT: Change in Management
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI (LODR) Regulations, 2015 and in compliance with section 108 of the Companies Act, 2013 read with rule 20 of the Companies (Management and Administration) Rules, 2014. |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Ltd (524396)
Pursuant to Regulation 30, 44 and 47 of SEBI(LODR) Regulations, 2015 and in compliance with Section 108 of the Companies Act, 2013 read with rule 20 of Companies (Management and Administration) Rules 2014 we enclosed herewith extract of newspaper published on 28th August 2026 in Free Press Mumbai (English) , Free Press Indore (English) and Choutha Sansar (Hindi) edition.
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Biofil Chemicals & Pharmaceuticals Ltd (524396)
Intimation for Dispatch of letter to those shareholders whose e-mail addresses are not registered with company/ registrar and share transfer agent/ depository participants
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23, 2026 |SUBJECT: Shareholders meeting
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Ltd (524396)
Submission of Integrated Annual Report for the Financial Year 2025-26 along with Notice convening the 41st Annual General Meeting as per Regulation 34 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Ltd (524396)
Submission of Notice of 41st AGM scheduled to be held on Wednesday 23rd September 2026 at 3:00 P.M. (IST) through video conferencing (VC)/ Other audio-visual means (OAVM)
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Limited
Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Ltd (524396)
Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015
Read Full Analysis →Biofil Chemicals & Pharmaceuticals Limited
Financial Results/Other business matters |Meeting Date: 11-Aug-2026
Read Full Analysis →Get instant alerts when BIOFILCHEM breaks news
Join investors who track Biofil Chemicals & Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for BIOFILCHEM?
BIOFILCHEM is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Biofil Chemicals & Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding BIOFILCHEM to your custom watchlist.